Cyclacel Pharmaceuticals Inc (CYCC)
2.29
-0.05
(-2.14%)
USD |
NASDAQ |
May 17, 16:00
2.29
0.00 (0.00%)
After-Hours: 20:00
Cyclacel Pharmaceuticals Cash from Operations (Quarterly): -3.91M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -3.91M |
| September 30, 2023 | -4.036M |
| June 30, 2023 | -1.305M |
| March 31, 2023 | -6.861M |
| December 31, 2022 | -5.169M |
| September 30, 2022 | -6.968M |
| June 30, 2022 | -1.915M |
| March 31, 2022 | -6.775M |
| December 31, 2021 | -4.549M |
| September 30, 2021 | -6.21M |
| June 30, 2021 | -4.215M |
| March 31, 2021 | -3.566M |
| December 31, 2020 | -1.152M |
| September 30, 2020 | -2.129M |
| June 30, 2020 | -1.846M |
| March 31, 2020 | -2.807M |
| December 31, 2019 | -1.117M |
| September 30, 2019 | -2.011M |
| June 30, 2019 | -2.635M |
| March 31, 2019 | -3.684M |
| December 31, 2018 | -2.036M |
| September 30, 2018 | -0.723M |
| June 30, 2018 | -1.803M |
| March 31, 2018 | -2.139M |
| December 31, 2017 | -2.22M |
| Date | Value |
|---|---|
| September 30, 2017 | -1.249M |
| June 30, 2017 | -0.201M |
| March 31, 2017 | -3.81M |
| December 31, 2016 | -2.943M |
| September 30, 2016 | -2.953M |
| June 30, 2016 | -1.036M |
| March 31, 2016 | -3.147M |
| December 31, 2015 | -2.676M |
| September 30, 2015 | -4.106M |
| June 30, 2015 | -2.778M |
| March 31, 2015 | -4.90M |
| December 31, 2014 | -3.668M |
| September 30, 2014 | -6.207M |
| June 30, 2014 | -4.101M |
| March 31, 2014 | -4.726M |
| December 31, 2013 | -5.378M |
| September 30, 2013 | -2.139M |
| June 30, 2013 | -5.314M |
| March 31, 2013 | -5.368M |
| December 31, 2012 | -2.459M |
| September 30, 2012 | -2.108M |
| June 30, 2012 | -3.705M |
| March 31, 2012 | -3.771M |
| December 31, 2011 | -3.259M |
| September 30, 2011 | -2.262M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-6.968M
Minimum
Sep 2022
-1.117M
Maximum
Dec 2019
-3.641M
Average
-3.566M
Median
Mar 2021
Cash from Operations (Quarterly) Benchmarks
| Corvus Pharmaceuticals Inc | -5.157M |
| Oragenics Inc | -1.102M |
| Relmada Therapeutics Inc | -13.04M |
| Alpine Immune Sciences Inc | -27.69M |
| MAIA Biotechnology Inc | -3.587M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | 0.999M |
| Free Cash Flow | -16.12M |
| Free Cash Flow Per Share (Quarterly) | -4.405 |
| Free Cash Flow to Equity (Quarterly) | -3.91M |
| Free Cash Flow to Firm (Quarterly) | -3.91M |
| Free Cash Flow Yield | -827.3% |